Cite

HARVARD Citation

    Tanaka, Y. et al. (2020). Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction. RMD open. 6 (2), p. . [Online]. 
  
Back to record